Exodus Point Capital Management, LP Kala Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $13,798 - $41,620	-22,620 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.16 - $2.74 $26,239 - $61,978	22,620 New	22,620 $27,000
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $78,204 - $109,461	-12,453 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $50,857 - $75,336	-6,781 Reduced 35.26%	12,453 $93,000
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $160,219 - $265,236	19,234 New	19,234 $202,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.69M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.